特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
949658

気管支炎治療の世界市場:2020-2026年

Global Bronchitis Treatment Market 2020-2026

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
気管支炎治療の世界市場:2020-2026年
出版日: 2020年06月27日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の気管支炎治療の市場は予測期間中にかなりの成長を示すと予測されています。高齢者人口の増加や大気汚染から、喘息および慢性閉塞性肺疾患 (COPD) の有病率が増加しており、これらの要因が同市場の成長を推進しています。薬剤区分の中では、気管支拡張薬が予測期間中に高いCAGRを示す見通しです。地域別では、北米地域が大きなシェアを占めると予測されており、高度に成熟し開発された医療インフラを持つ米国は高度な治療ソリューションの開発に貢献しています。また、総人口の増加、高齢者人口の増加、工業化の加速とそれに伴う大気汚染のレベルが上昇などの要因から、アジア太平洋地域が予測期間中、高い成長率を示す見通しです。

当レポートでは、世界の気管支炎治療の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、関連法規制、市場規模の推移・予測、治療区分など各種区分別の内訳、地域・主要国別の詳細分析、競合環境、企業シェア、主要企業のプロファイルなどをまとめています。

第1章 レポート概要

第2章 市場概要・考察

  • 調査範囲
  • アナリストの見解・現在の市場動向
  • 法規制

第3章 競合情勢

  • 企業シェア分析
  • 主要戦略の分析
  • 主要企業の分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の展開

第4章 市場影響因子

  • 成長推進因子
  • 成長抑制因子
  • 市場機会

第5章 市場分析・予測:各種区分別

  • タイプ別
    • 薬剤
    • 酸素療法

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第7章 企業プロファイル

  • Abbott Laboratories
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd.
  • Dr Reddy's Laboratories Ltd.
  • GlaxoSmithKline PLC
  • Lupin Pharmaceuticals, Inc.
  • Mayne Pharma Group Ltd.
  • Merck & Co., Inc.
  • Mucinex (Reckitt Benckiser Group plc)
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
図表

LIST OF TABLES

  • 1. GLOBAL BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL BRONCHITIS TREATMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL BRONCHITIS TREATMENT OXYGEN THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)

4. GLOBAL BRONCHITIS TREATMENT OXYGEN THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-

  • 5. GLOBAL BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 6. NORTH AMERICAN BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 7. NORTH AMERICAN BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 8. EUROPEAN BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 9. EUROPEAN BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 10. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 11. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 12. REST OF THE WORLD BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BRONCHITIS TREATMENT MARKET SHARE BY TYPE, 2019 VS 2026 (%)
  • 2. GLOBAL BRONCHITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 3. US BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 4. CANADA BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. UK BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. FRANCE BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. GERMANY BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. ITALY BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. SPAIN BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. ROE BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. INDIA BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. CHINA BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. JAPAN BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. REST OF ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF THE WORLD BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
目次
Product Code: OMR2021977

Global Bronchitis Treatment Market Size, Share & Trends Analysis Report by Type (Drugs (Antibiotics, Anti-Inflammatory Drugs, Bronchodilators, and Others) and Oxygen Therapy) and Forecast 2020-2026

The global bronchitis treatment market is projected to witness considerable growth during the forecast period. The major factors contributing to the growth of the market include the rising geriatric population and air pollution, which in turn, is increasing the prevalence of asthma and chronic obstructive pulmonary disease (COPD) across the globe. With the rise in these respiratory diseases, the incidence rate of bronchitis increases, which in turn, is offering growth to the market across the globe. The bronchitis treatment market is classified on the basis of type of treatment, which includes drugs and oxygen therapy. The drugs segment is further segregated into antibiotics, anti-inflammatory drugs, bronchodilators, and others. Among these types of treatments, the drugs find its significant application in the bronchitis treatment across the globe. In addition, the bronchodilator is estimated to project a considerable CAGR during the forecast period.

Geographically, the global bronchitis treatment market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to contribute a significant share in the global market. The US with a highly matured and developed healthcare infrastructure, contributes to the development of advanced treatment solution for bronchitis. The US has a high spending on healthcare R&D and high prevalence of asthma, which in turn, offers growth to the bronchitis treatment market in North America. In addition, Asia-Pacific is expected to project a considerable growth during the forecast period. This growth is backed by the rising population leading to the rise in geriatric population and increase in industrial sector in the region, especially in India, China, South Korea, and Japan. With the rise in industrialization, the level of air pollution will rise, which in turn, will augment the growth of the bronchitis treatment market in Asia-Pacific.

The global bronchitis treatment market is influenced by product development and advancements conducted by the market players. The key players of the bronchitis treatment market include Abbott Laboratories, Bayer AG, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. These players are playing a significant role in the growth of the bronchitis treatment market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the global bronchitis treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Bronchitis Treatment Market Research and Analysis by Type

The Report Covers:

  • Comprehensive research methodology of the global bronchitis treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global bronchitis treatment market.
  • Insights about market determinants which are stimulating the global market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Bronchitis Treatment Market by Type
    • 5.1.1. Drugs
      • 5.1.1.1. Antibiotics
      • 5.1.1.2. Anti-inflammatory drugs
      • 5.1.1.3. Bronchodilators
      • 5.1.1.4. Others (Mucolytics)
    • 5.1.2. Oxygen Therapy

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. Aurobindo Pharma Ltd.
  • 7.3. Bayer AG
  • 7.4. Boehringer Ingelheim International GmbH
  • 7.5. Cipla Ltd.
  • 7.6. Dr Reddy's Laboratories Ltd.
  • 7.7. GlaxoSmithKline PLC
  • 7.8. Lupin Pharmaceuticals, Inc.
  • 7.9. Mayne Pharma Group Ltd.
  • 7.10. Merck & Co., Inc.
  • 7.11. Mucinex (Reckitt Benckiser Group plc)
  • 7.12. Novartis AG
  • 7.13. Pfizer Inc.
  • 7.14. Sanofi SA
  • 7.15. Teva Pharmaceutical Industries Ltd.
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.